Literature DB >> 6369973

Significance of immunoglobulin G subclasses.

D C Heiner.   

Abstract

IgG subclasses differ from one another both immunochemically and functionally. An isolated absence of a certain specific subclass may or may not be associated with disease. However, an absence of serum IgG4 as measured by a sensitive radioimmunoassay is usually, if not always, associated with severe recurrent pyogenic infections, usually of the respiratory tract. IgG2 and IgG4 deficiencies tends to occur together, often in association with deficiencies of immunoglobulin A (IgA) and/or immunoglobulin E (IgE). The properties of IgG1 are similar to those of IgG3 and those of IgG2 appear to resemble those of IgG4 in certain respects. Specific combined deficiencies tend to be associated with certain diseases. Some patients with deficiency of an immunoglobulin G (IgG) subclass appear able to compensate and to avoid clinical disease whereas others are not. Overlap zones exist in the lower ranges of serum concentrations in which both healthy and immunoincompetent subjects are found. It is important to consider the concentration of each IgG subclass present in a gamma globulin preparation or in plasma used for replacement therapy. If specific antibody deficiencies exist, it may be critical that the preparation used for replacement contains goodly amounts of the missing antibodies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6369973     DOI: 10.1016/0002-9343(84)90313-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  Cytokine responses of human blood monocytes stimulated with Igs.

Authors:  J L Foreback; D G Remick; E Crockett-Torabi; P A Ward
Journal:  Inflammation       Date:  1997-10       Impact factor: 4.092

2.  Non-infective colitis in infancy: evidence in favour of minor immunodeficiency in its pathogenesis.

Authors:  A Ojuawo; D St Louis; K J Lindley; P J Milla
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

3.  Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls.

Authors:  M G Scott; M H Nahm; K Macke; G S Nash; M J Bertovich; R P MacDermott
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

Review 4.  IgG subclass-restricted immune responses to allergens.

Authors:  A H Lucas
Journal:  Springer Semin Immunopathol       Date:  1990

Review 5.  IgG4-associated vasculitis.

Authors:  Rodolfo Perez Alamino; Carlos Martínez; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

6.  A case of IgG4-related tubulointerstitial nephritis concurrent with Henoch-Schönlein purpura nephritis.

Authors:  Rukako Tamai; Yoshiyuki Hasegawa; Satoshi Hisano; Katsuhisa Miyake; Hitoshi Nakashima; Takao Saito
Journal:  Allergy Asthma Clin Immunol       Date:  2011-03-31       Impact factor: 3.406

7.  Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives.

Authors:  L Biancone; G Monteleone; R Marasco; F Pallone
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

8.  Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.

Authors:  E Brouwer; J W Tervaert; G Horst; M G Huitema; M van der Giessen; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

9.  Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents.

Authors:  E M el Amin; E P Wright; A Vlug
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  An investigation into the effect of the IgG antibody system on the susceptibility of IgA-deficient patients to respiratory tract infections.

Authors:  M A French; G Harrison
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.